Leukemia Stem Cell Treatment in Delhi, India

Leukemia is a category of cancer affecting the blood and bone marrow. It is characterized by the rapid production of abnormal white blood cells, which can crowd out healthy cells in the bone marrow and interfere with the production of normal blood cells.

These abnormal cells are immature, meaning they are still developing and do not function properly. Leukemia is caused by a mutation in the DNA of a single cell located in the bone marrow.

Treatment for leukemia varies depending on the type, the patient’s age and general health, and whether the cancer has spread to other parts of the body.

Research has shown that a bone marrow transplant for leukemia can successfully replace defective blood stem cells with healthy ones in the body.

For many people diagnosed with leukemia, a bone marrow transplant can offer a meaningful chance of remission or long-term disease control, though outcomes vary by leukemia subtype, remission status and individual health, and are not guaranteed for every patient.

A bone marrow transplant involves the infusion of healthy stem cells from the bone marrow into the body. This can help replace damaged bone marrow cells and create healthy blood cells. The donor’s marrow is removed from the back of the pelvic bone with a needle. The new marrow is then injected into the patient’s bloodstream.

After the transplant, the patient must stay in the hospital for several weeks to be monitored. Medications are given during this period to protect the body from infection and to prevent the new marrow from being rejected.

There are several types of leukemia, which can be classified into the following categories:

• Acute lymphocytic leukemia (ALL): This type is more common in children than in adults. ALL starts in the early forms of lymphocytes, a type of white blood cell that helps the body fight infection.
• Acute myeloid leukemia (AML): AML starts in myeloid cells, immature blood cells that eventually develop into red blood cells, white blood cells, and platelets. This condition is more common in adults than in children.
• Chronic lymphocytic leukemia (CLL): It affects the lymphocytes that develop into B-cells, which produce antibodies to fight infection. Adults are most likely to have CLL, which usually progresses slowly.
• Chronic myeloid leukemia (CML): CML starts in myeloid cells and tends to progress more slowly than AML. It is rare in children and more common in adults.

A mutation in the DNA of a single cell in the bone marrow causes leukemia. This mutation damages the cell’s DNA, leaving the cell unable to carry out its normal functions.

The mutated cell then begins to reproduce uncontrollably, giving rise to a large number of abnormal cells that also carry the same mutated DNA. It is not yet known exactly why these mutations occur, although some shared mutations have been identified across different types of leukemia.

It is not possible to prevent leukemia; however, certain factors may increase the risk of developing it, including:

• Family history of leukemia
• Having a genetic disorder such as Down syndrome
• Having undergone chemotherapy and radiation treatment for cancer
• Smoking
• Exposure to certain chemicals and high levels of radiation

The results of a routine blood test may indicate to your healthcare provider that you may have either an acute or chronic form of leukemia, which will require further testing. If you are exhibiting symptoms of leukemia, your provider may recommend a workup.

Tests and examinations might include the following:

• Physical examination: Your healthcare provider will assess your symptoms, feel for swollen lymph nodes and an enlarged spleen or liver, inspect your gums for bleeding and swelling, and look for a skin rash associated with leukemia.
• Complete blood count: With the help of this test, your doctor will find out if you have unusual levels of white blood cells, red blood cells, and platelets. If you have leukemia, you are most likely to have higher-than-average numbers of white blood cells.
• Bone marrow biopsy: Your healthcare provider may perform a biopsy if you have an abnormal white blood cell count. A bone marrow biopsy involves inserting a long needle into your bone marrow to draw out fluid, which is then tested in a lab for leukemia cells and to determine the proportion of abnormal cells in your bone marrow.
• Lumbar puncture: The healthcare provider may test a sample of spinal fluid to check whether leukemia has spread to the brain and spinal cord.
• Imaging and other exams: Your doctor may order imaging tests such as a chest X-ray, CT scan, or MRI to check for leukemia-related complications. These tests will not show leukemia cells themselves.
• Blood cell examination: Your healthcare provider may take additional blood samples and order tests, such as flow cytometry and a peripheral blood smear, to check for markers that indicate the presence of leukemia cells or a particular type of leukemia.

Bone Marrow Transplant for Leukemia in India

Located in the center of certain bones, bone marrow is a soft, fatty tissue that produces stem cells. These stem cells have the potential to develop into various types of blood and immune cells, including red blood cells, white blood cells, and platelets.

When a person is suffering from a condition like leukemia that affects the bone marrow, a bone marrow transplant can be a helpful treatment option.

A bone marrow transplant for leukemia is aimed at achieving complete remission, meaning there are no more signs or symptoms of the disease after the therapy is completed.

There are other treatments as well, such as leukemia stem cell treatment, which can help patients recover by replacing old, unhealthy cells with new, healthy ones.

There are two main types of bone marrow transplant treatment for leukemia:

• Autologous Transplant: This treatment uses bone marrow from the patient’s own body.
• Allogeneic Transplant: For this treatment, your healthcare provider will use bone marrow cells from a matched donor.

Bone Marrow Transplant for Children

A bone marrow transplant for childhood leukemia is a medical procedure done to replace diseased bone marrow in a child with healthy bone marrow.

The stem cells from the healthy bone marrow are filtered and then reintroduced, either into the same child or into another child who is also affected. These stem cells, referred to as the graft, grow and form new, healthy bone marrow, which helps fight the disease.

The purpose of bone marrow transplantation is to treat cancer by replacing cancerous cells in a patient’s bone marrow with healthy, new blood-forming stem cells.

This procedure has two main approaches: allogeneic, in which stem cells are taken from a donor, either unrelated or partially mismatched, and autologous, which involves the use of a patient’s own stem cells collected prior to chemotherapy. This treatment also suppresses the patient’s immune system, making it easier for the transplanted cells to take hold and grow.

Once cancerous cells have been cleared from a patient’s bone marrow, healthy bone marrow stem cells from a donor are infused into the patient’s bloodstream, much like a blood transfusion. These transplanted cells travel to the patient’s bone marrow and start producing healthy blood cells.

To reduce the risk of the patient’s immune system rejecting the donor cells, the donor and patient must be matched for certain genetic markers. This matching can involve a sibling or an unrelated donor.

After transplantation, the healthy stem cells replicate and produce new blood cells and bone marrow.

How well a bone marrow transplant for leukemia works depends on various factors, such as:

• Type of transplant
• Stage and severity of the condition
• Overall health and the patient’s age
• How the patient’s body responds to the procedure
• Complications and other health conditions

Autologous bone marrow transplants are typically more tolerable for the body than allogeneic transplants, reducing the chances of certain complications. However, a major downside of this type of transplant is that some leukemia cells may return, even after the collected stem cells have been treated in a laboratory — a stage known as relapse.

Stem cell therapy for Leukemia is discussed only after an individual medical evaluation, and safety depends heavily on that case-by-case review rather than on the therapy in general. As with any medical intervention, mild and temporary reactions (such as soreness or fatigue at the injection or infusion site) are possible, and a full risk discussion happens as part of your evaluation. It is not offered to patients in an acute or unstable phase of Leukemia, and it is never positioned as a substitute for guideline-based care from your treating specialist. For a fuller picture of how safety, accreditation, and quality standards are handled, see our Safety and Guarantees page.

This list is general and educational — it is not a substitute for an individual medical evaluation of your case.

A supportive-care discussion for Leukemia isn't a single conversation — it follows a defined sequence, so nothing is recommended before your specific case has been reviewed. In broad terms:

1. Record review: Your existing diagnosis, imaging, lab work, and treatment history for Leukemia are reviewed by the medical team first.
2. Case-by-case medical evaluation: A physician assesses whether any further discussion is medically reasonable for your specific case — many enquiries end here with a clear "not appropriate" answer, which is a valid and expected outcome.
3. Coordination with your specialist: Where a discussion proceeds, it is coordinated so it does not conflict with your ongoing care from your treating specialist.
4. Transparent, written explanation: Any recommendation is explained in plain language, including its investigational status, realistic expectations, and that no outcome is guaranteed.
5. Ongoing standard care continues: At every stage, your prescribed treatment for Leukemia continues unless your own treating specialist changes it.

Nothing is scheduled or billed during this stage — it is a review and conversation, not a commitment.

We believe in the power of hope and the potential of healing. Our medical team is dedicated to offering you the highest quality of care and services tailored to your individual needs. We strive to provide a comprehensive and integrative approach to wellness in order to help you achieve your best possible health. With our innovative treatments, world-class amenities, and dedicated medical staff, we are here to support you on your journey to improved well-being.

Facing a disease that has a serious impact on one’s life can be an agonizing experience for both the patient and their family. A bone marrow transplant can potentially enhance the patient’s quality of life.

India has seen exponential growth in medical research and technology, making it a cost-effective place to have a bone marrow transplant. As a hospital experienced in leukemia treatment, bone marrow transplant, and leukemia stem cell transplant, we provide the necessary facilities for the treatment procedure.

We provide bone marrow transplants in India at a comparatively low cost, which has drawn the attention of many international patients.

However, several factors can affect the cost of a bone marrow transplant, including:

• Location of the hospital
• Patient’s age and relationship with the donor
• Type of transplant
• Overall medical health of the patient
• Post-surgical issues
• Additional lab examinations and tests

If you want to know more about our treatment, you can connect with our team of experts, who will guide you through each step of the procedure and offer 24/7 assistance.

A bone marrow transplant may be an effective treatment for some individuals facing leukemia. By replacing damaged cells with healthy ones, there is a lower chance of experiencing further bone marrow damage or a relapse. This procedure can potentially improve survival rates for those with leukemia.

The outlook for an individual after bone marrow transplant (BMT) for leukemia depends on several factors, including age, general health, and how far the disease has progressed.

Outcome expectations for potential transplant patients are determined through a multivariate analysis that takes into account the patient’s age, performance status, any other medical conditions, family support structure, socioeconomic status, and motivation to engage in self-care. To assess the patient’s physiological status, the center typically performs a comprehensive health history, physical examination, and clinical testing.

A bone marrow transplant for leukemia, also known as a leukemia stem cell transplant, is a procedure used to treat certain types of cancer or immune diseases. The transplant involves infusing healthy cells — either donated from another person or the patient’s own cells — into the bloodstream through an intravenous line. This process replaces diseased cells with healthy cells.

A bone marrow transplant can be used to:

• Replace or rescue bone marrow damaged by high doses of chemotherapy or radiation, allowing treatment to proceed safely.
• Replace defective bone marrow with new stem cells.
• Supply fresh stem cells that can target and eliminate cancer cells.

As a hospital experienced in leukemia treatment, Stem Cell Care India offers several benefits for those opting for a bone marrow transplant:

• Patients typically require only a 3-day hospital stay for treatment, after which they can return to their normal activities.
• Long-term follow-up studies report that remission achieved through stem cell transplantation can be sustained for many patients, though outcomes vary and relapse remains a risk.
• We also provide travel planning and post-therapy follow-up assistance to make your trip to India smooth and comfortable.
• We ensure quality patient care by employing only qualified staff, keeping treatment efficient and free of unnecessary risk.
• SCCI’s stem cell therapy is cost-effective and meets international standards for quality and facilities.

At our facility, we have implemented strict quality control standards to ensure the safety and efficacy of our treatments. These standards have been created with the patient’s best interests in mind and are aligned with international guidelines. As a result, most patients we have treated have seen notable improvements in their condition and overall quality of life.

Some of our essential quality control standards include:

• All batches of stem cells are inspected for the possibility of infectious organisms to prevent contamination.
• Stem cell batches are rigorously checked. Disinfection of media used for processing and treatment is essential to eliminate Gram bacteria and mycoplasma.
• Every group of stem cells is tested for endotoxin levels, which must meet the required limit to guarantee safety.
• As part of quality control, cells are examined for any mutations, alterations, or contaminating organisms after the final wash.

A “Certificate of Analysis” accompanies every batch of stem cells, guaranteeing its authenticity and quality and assuring the patient of the procedure’s reliability.

Bone marrow transplants have become more successful with advances in medicine, with outcomes depending on the underlying disease, source of cells, and the patient’s general health. Life expectancy has improved significantly compared to the last decade.

Before undergoing a stem cell transplant or bone marrow transplant for leukemia, a patient completes a conditioning regimen. This may involve high doses of chemotherapy and/or radiation therapy, or in some cases reduced-intensity conditioning, which uses lower, less toxic chemotherapy doses and/or pre-transplant total body irradiation.

Once this preparatory process is complete, the transplant can proceed. The stem cells are given intravenously, similar to a blood transfusion, and this typically takes over an hour. The stem cells then migrate to the bone marrow and begin making new blood cells, a process known as engraftment. Established stem cell hospitals like SCCI aim to offer affordable treatment for leukemia.

Ayesha Ahmed from Dubai came to India for a bone marrow transplant

I am absolutely overjoyed with the care I received at Stem Cell Care India. The doctors were accommodating and understanding. They were able to explain the treatment process to me in a way that made a complex procedure easy to understand. I had complete faith in them, and the outcome was excellent. I am grateful to everyone at the clinic.

Prakash Jha from Ranchi visited SCCI to treat leukemia

I arrived at Stem Cell Care India searching for a cure for my condition, feeling desperate and helpless. I opted for bone marrow treatment for leukemia, and to my surprise, the therapy proved to be a turning point. In a matter of weeks, my symptoms had partially disappeared, and I could live my life more normally. Thanks to the bone marrow treatment I received for leukemia in Delhi and all the doctors at SCCI, I have been given a second chance at life.

Reshma from Abu Dhabi underwent a bone marrow transplant for leukemia in India

Reshma was suffering from leukemia and was looking for an effective and safe treatment option. After hearing many patient reviews, she decided to look into bone marrow treatment. After researching, she found our site and was delighted to find that it offered the therapy at a fraction of the cost she had seen elsewhere online. She called and spoke with one of our experts, who guided her through the entire process. To her surprise, the treatment was virtually painless and resulted in excellent results with no side effects.

Jacob Greens from Ireland came to us for treatment of leukemia

For quite some time, I had been struggling with leukemia and had tried many different treatments without much success, becoming increasingly anxious about my condition. Fortunately, I came across Stem Cell Care India and its bone marrow treatment for my condition. I am so glad I decided to take that chance, because the results have been remarkable. I am feeling much better now, and I am very grateful to the doctors for providing me with such an effective treatment.

Each patient receives external verification to confirm the quality and availability of the cells used in their treatment. This meticulous process ensures that the cells delivered meet the highest industry standards. The rigorous testing also confirms that the cells are viable and suitable for use in treatment. This process is one of the most important steps in providing optimal care for patients, as it confirms that the cells are both safe and effective. Through this process, patients can be confident that the cells they receive are of the highest quality and will support the best possible outcomes.

The staff at Stem Cell Care India will keep in touch with you over the course of the next year and a half, checking in at one-month, two-month, and six-month intervals to assess the progress of your treatment. This allows us to refine our processes and continually improve our services. Please do not hesitate to contact us if you need any additional help during this time.

Stem cell therapy is generally discussed as one part of a broader recovery plan rather than a stand-alone treatment. Supportive therapies sometimes used alongside it for leukemia include:

• Psychological support: To help address mood changes, anxiety, or emotional stress that can follow a leukemia.
• Speech therapy: For patients experiencing difficulty speaking, swallowing, or understanding language.
• Physiotherapy: To help rebuild movement, balance, and muscle strength.
• Hyperbaric oxygen therapy: Delivering oxygen at increased pressure, which is being explored as a supportive measure for tissue recovery.
• Acupuncture: Used by some patients as a complementary approach alongside conventional care.
• Rehabilitation therapy: Structured practice of daily tasks to support functional recovery.
• Occupational therapy: Support for relearning tasks such as dressing, eating, and writing.
• Nutrition therapy: Dietary guidance intended to support general recovery.
• Nerve Growth Factor (NGF) treatment: Supports the survival and growth of nerve cells; when discussed alongside stem cell therapy, it is explored for its potential to support nerve repair and overall brain recovery.

Any combination of these should be planned together with the treating medical team rather than pursued independently.

Leukemia affects patients worldwide, and because it can disrupt memory, movement, or cognitive activity, many patients look beyond their home country for treatment options to discuss with a physician. A number of international patients — including from the United States, Europe, the United Kingdom, the UAE, Thailand, and Nepal — have looked into evaluation and care options in India as part of that search. Considerations patients commonly cite when comparing India with other locations include:

• Established medical infrastructure and equipment at accredited facilities
• A large pool of trained physicians and researchers, including many with international training
• Costs that are often lower than in Western countries for comparable services
• Individualized treatment planning tailored to each patient's needs
• Support services such as airport transfers, medical visa assistance, and multilingual staff for international patients
• Access to post-treatment rehabilitation support, including physiotherapy and follow-up consultation
• Positive treatment experiences reported by many patients who have travelled for care, though individual outcomes still vary

These are general considerations reported by patients and are not a guarantee of any particular outcome, cost, or experience.